ArticleAnnals of hematology2025

Zanubrutinib plus salvage chemotherapy in patients with refractory/relapsed diffuse large B-cell lymphoma non-candidate for autologous stem cell transplantation: A retrospective study.

Sha He et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.